Company Profile
PharmaVision was created by Dr Cheryl Lee Barton in 2002 to provide independent, tailor made pharmaceutical thematic research to investment houses, competitive intelligence specialists and pharmaceutical companies. The research reports combine independent scientific analysis with market models to forecast the potential growth of key developmental products and technologies.
Pharmavision was formed in order to write and publish independent and impartial analysis of the pharmaceutical industry with a focus on drug delivery, it’s players, their products and the issues surrounding this specialist sector. Using PharmaVision's market modeling and analysis insight, we aim to deliver market analysis papers of quality and value to its readers.
Latest Papers
 Delivering RNAi-Based Therapeutics & DiagnosticsChallenges & Opportunities “Several novel RNAi-based therapeutics are expected to be launched in the next ten years as companies have made significant advances in identifying, characterising, designing and delivering gene silencing agents to a variety of target tissues. A plet... Price: £945.00 Author: Dr Cheryl L Barton / Date Published: 01 July 2009 |
|
Accelerating Lead Generation: Emerging technologies and strategies It is well documented that productivity in the pharma industry is in decline. Over the past 15 years the number of new drug applications (NDAs) and biologics license applications (BLAs) approved has fallen steadily, despite an ever increasing R&D spe... Price: £1,995.00 Author: Dr Cheryl L Barton / Date Published: 01 June 2009 |
|
Early Stage Drug Safety Strategies & Risk Management Maximizing opportunities towards achieving clinical success Declining industrial productivity has forced companies to urgently address the areas of drug development that are most likely to lead to the failure of a new compound. Innovations are required that can support the earlier termination of drugs which w... Price: £1,995.00 Author: Dr Cheryl L Barton / Date Published: 20 April 2009 |
